IP Library Granted Patent US 9,179,964
Granted Patent B2
US 9,179,964 · App. 14/607,639 · Granted Nov 10, 2015

Methods and devices to treat nasal airways

Inventors: Scott J. Wolf (Menlo Park, CA); Andrew Frazier (Sunnyvale, CA)
Assignee: AERIN MEDICAL, INC.
A61B18/1477A61B18/02A61B18/1206A61B18/1442A61B18/1485A61B18/16A61F5/08A61F7/10A61N1/403A61N5/025A61N5/0603A61N5/0625A61N7/022A61B2018/00005A61B2018/00023A61B2018/00327A61B2018/00577A61B2018/00595A61B2018/00702A61B2018/00791A61B2018/00821A61B2018/00886A61B2018/00922A61B2018/0212A61B2018/126A61B2018/1253A61B2018/143
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,179,964
App. No.
14/607,639
Granted
Nov 10, 2015
Kind
B2
Abstract

A method is described for modifying at least one property of a tissue of or near a nasal valve of a nose, without using a surgical incision or an implant, to decrease airflow resistance or perceived airflow resistance in a nasal airway. The method may involve contacting a treatment element of a treatment device with the at least one tissue inside the nasal airway, with sufficient force to at least temporarily deform the at least one tissue, applying energy to, or removing energy from, the at least one tissue, using the treatment element, and removing the treatment element from the nostril.

Claims (9)

1. A method of modifying a property of a nasal tissue of or near a nasal valve of a nose, without using a surgical incision or an implant, to decrease airflow resistance or perceived airflow resistance in a nasal airway, the method comprising:

contacting a treatment element of a cryotherapy treatment device with the nasal tissue inside the nasal airway;

removing energy from the nasal tissue using the treatment element of the cryotherapy treatment device to modify the property of the nasal tissue, wherein the nasal tissue at least partially maintains the modified property after the treatment element is removed and the nasal tissue heals; and

removing the treatment element from the nostril.

2. The method of claim 1 , wherein removing energy from the nasal tissue comprises delivering cryotherapy uniformly over an entire outer surface of the treatment element, thereby treating all nasal tissue in contact with the treatment element.

3. The method of claim 1 , wherein removing energy from the nasal tissue comprises engaging elements distributed across the treatment element to cool only targeted areas of the nasal tissue.

4. The method of claim 1 , wherein the property of the nasal tissue comprises the tightness of one or more sections of an epithelium of an inner surface of the nasal valve.

5. The method of claim 1 , wherein the property of the nasal tissue comprises the strength of cartilage in the area of the upper lateral cartilage.

6. The method of claim 1 , wherein removing energy from the nasal tissue creates localized tissue damage.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Dec 20, 2024
From: CRG SERVICING LLC
To: AERIN MEDICAL INC.
Reel/Frame 069654/0467 →
SECURITY INTEREST Recorded Dec 20, 2024
From: AERIN MEDICAL INC.
To: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 069746/0508 →
SECURITY INTEREST Recorded May 13, 2019
From: AERIN MEDICAL INC.
To: CRG SERVICING LLC
Reel/Frame 049161/0043 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2019
From: WOLF, SCOTT J.; FRAZIER, ANDREW
To: AERIN MEDICAL, INC.
Reel/Frame 048342/0635 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 19, 2015
From: WOLF, SCOTT J.; FRAZIER, ANDREW
To: AERIN MEDICAL, INC.
Reel/Frame 036360/0885 →
Continuity (5)
Continuation 14026922 · Sep 13, 2013
Continuation In Part 13495844 · Jun 13, 2012
Provisional Application 61496930 · Jun 14, 2011
Provisional Application 61603864 · Feb 27, 2012
Related Publication 20150157395A1 · Jun 11, 2015